Market Size of Diagnostic Imaging Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Diagnostic Imaging Market Analysis
The diagnostic imaging market is expected to register a CAGR of nearly 6.1% during the forecast period.
The COVID-19 pandemic was expected to have a significant impact on the market. According to an article published in European Radiology in November 2020, chest radiography was useful in identifying COVID-19 patients who may rapidly deteriorate and helping inform clinical management and hospital bed and ventilation allocation. This increased the demand for chest radiography during the pandemic phase. Similarly, in April 2020, the National COVID-19 Chest Imaging Database (NCCID) was launched in the United Kingdom, which provides a more comprehensive understanding of COVID-19 by collating X-rays, CT, and MRI scan data from 20 NHS trusts across the country to detect disease patterns and markers of the virus using Artificial Intelligence (AI), which, in turn, enabled more accurate early diagnoses and prognoses. This is expected to boost the demand for such equipment and tests during the COVID-19 pandemic. In addition, the demand for diagnostic imaging is expected to remain constant due to the reopening of diagnostic clinics and hospitals with high patient inflow, thereby contributing to the growth of the market over the coming five years.
The main things that are driving the growth of the diagnostic imaging market are the increase in chronic diseases, the rise in the number of older people, and the use of more advanced imaging technologies.
The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases, thereby contributing to the growth of the market. According to GLOBOCAN, in 2020, about 19.3 million new cases of cancer were reported worldwide, and this number is expected to increase to 30.2 million in 2040. Such an increase in cancer cases is expected to contribute to the growth of the market over the forecast period. Similarly, the British Heart Foundation data published in January 2022 reported that the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million), and atrial fibrillation (60 million). Such a large prevalence globally is fueling the growth of the market.
Additionally, the increasing number of product launches is expected to contribute to the growth of the market. For instance, in March 2021, Hitachi Medical Systems launched two permanent open MRI systems, APERTO Lucent Plus and AIRIS Vento Plus, at the start of the 2021 European Congress of Radiology. Both systems are equipped with SynergyDrive workflow solutions.
Thus, the above-mentioned factors are expected to contribute to the growth of the market over the forecast period.
